BRIAN CEY: Open Payments
NPI 1659939031 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 61 payments from 24 companies in 2025. Trend: 2023 $224 · 2024 $1,053 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $244 |
| Novo Nordisk Inc | 9 | $160 |
| ABBVIE INC. | 5 | $130 |
| Medtronic, Inc. | 3 | $66 |
| Amgen Inc. | 4 | $64 |
| Exact Sciences Corporation | 2 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Lilly USA, LLC | 3 | $44 |
Products named: UBRELVY, PREVNAR 20, ELIQUIS, Wegovy, Ozempic, INCEPTIV, EVENITY, Cologuard Collection Kit.
Industry payments across ID — which companies pay providers there.
